Showing 2391-2400 of 2839 results for "".
- What is Exosome Therapy? All Your Questions Answeredhttps://modernaesthetics.com/news/what-is-exosome-therapy-all-your-questions-answered/2473445/Exosomes are among today’s buzziest skincare ingredients, but what exactly are exosomes, how can you choose the best product to recommend to patients, and how can exosomes be used to complement in-office skin rejuvenation procedures? New York City dermatologist Marina I. Pere
- WCD News: Deka Rolls Out Three New Laser and Microwave Platformshttps://modernaesthetics.com/news/wcd-news-deka-rolls-out-three-new-laser-and-microwave-platforms/2473441/DEKA is launching of its new PRO line at the 25th World Congress of Dermatology in Singapore. Based on laser and microwave technology, the line includes the Again PRO, RedTouch PRO, and Onda PRO platforms. The Again PRO platform, a combinatio
- Merz Aesthetics Named Sole Distributor of AccuVein’s Visualization Systemhttps://modernaesthetics.com/news/merz-aesthetics-named-sole-distributor-of-accuveins-visualization-system/2473439/Merz Aesthetics is now the sole authorized distributor of AccuVein’s vein visualization system in the U.S. aesthetics market. A limited initial AccuVein field pilot yielded positive results and significant expansion of both new customers and Merz Aesthetics portfolio ad
- Xeomin Performs Well in Phase 3 Studies of Upper Facial Lineshttps://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as
- Study: Belotero Balance (+) Restores Volume to Under-eye Hollowshttps://modernaesthetics.com/news/study-belotero-balance-restores-volume-to-under-eye-hollows/2473429/Belotero Balance® (+) corrects volume loss in the infraorbital hollow area, according to new data from Merz Aesthetics. Merz Aesthetics will submit these data as part of a supplemental Premarket Approval Application (sPMA) with the U.S. Food and Drug Administration (FDA) this
- IL-17 Linked to Skin Aging: Studyhttps://modernaesthetics.com/news/il-17-linked-to-skin-aging-study/2473426/Interleukin (IL)-17 may plays a central role in skin aging, according to research from Institute for Research in Biomedicine (IRB Barcelona) in collaboration with the National Center for Genomic Analysis (CNAG). The study, which was led by Dr. Guiomar Solanas, Dr. Salvador Azn
- Eyebrow Thickness? It’s in Your Geneshttps://modernaesthetics.com/news/eyebrow-thickness-its-in-your-genes/2473425/The first gene mapping study on eyebrow thickness in Europeans discovered three previously unreported genetic loci, suggesting that eyebrow appearance has partly the same and partly different underlying genes in people from different parts of the world. The study, conducted by the Inter
- FDA Approves Galderma's Restylane Eyelighthttps://modernaesthetics.com/news/fda-approves-galdermas-restylane-eyelight/2473423/The U.S. Food and Drug Administration (FDA) approved Restylane Eyelight, a hyaluronic acid (HA) dermal filler for the correction of undereye hollowing, in adults over the age of 21. Restylane Eyelight is formulated with NASHA Technology, which has a firm gel te
- BTL Takes on Music Festival Season With Emfesthttps://modernaesthetics.com/news/btl-takes-on-music-festival-season-with-emfest/2473422/BTL’s Emfest is coming to set to the Pasea Resort and Spa in Huntington Beach, Calif. The event, slated for Aug. 26, 2023, will feature a diverse lineup of music performances. In addition to the musical aspect, Emfest will provide a wide range of wellness activities and
- Radiofrequency Microneedling: Optimize Your Resultshttps://modernaesthetics.com/news/radiofrequency-microneedling-optimize-your-results/2473417/For optimal results when treating patients with radiofrequency (RF) microneedling, anecdotal and personal experience guide Elizabeth L. Tanzi, MD, as there are “No significant comparison studies to date” on the